TY - CHAP M1 - Book, Section TI - Schizophrenia MTM Data Set A1 - Caley, Charles F. A2 - Whalen, Karen A2 - Hardin, Heather C. PY - 2018 T2 - Medication Therapy Management: A Comprehensive Approach, 2e AB - KEY POINTSAppropriate evaluation of schizophrenia includes assessment of positive symptoms, negative symptoms, and cognitive deficit severity. Medication therapy management (MTM) providers working with patients with schizophrenia should be adequately trained in the use of common rating scales.MTM providers should educate patients to be realistic about the expected outcomes of antipsychotic therapy, ie, even when medication is taken as prescribed, there will be occasional days where symptoms of schizophrenia may be bothersome.Nonadherence is a common medication-related problem in patients with schizophrenia. MTM providers should be vigilant for nonadherence and work with the patient and provider to find a regimen that promotes adherence and minimizes adverse effects and drug cost.Metabolic syndrome and extrapyramidal symptoms are concerning adverse effects of antipsychotic drug therapy. MTM providers should monitor for these adverse effects and recommend appropriate changes in therapy to help minimize their consequences. SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/29 UR - accesspharmacy.mhmedical.com/content.aspx?aid=1150202247 ER -